CANCER GENETICS, INC Uncategorized Contracts & Agreements

31 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities
CANCER GENETICS, INC
Biotechnology
DE
2023
Description of Securities
CANCER GENETICS, INC
Biotechnology
DE
2022
Description of Securities
CANCER GENETICS, INC
Biotechnology
DE
2021
Form of Engagement Agreement, dated September 18, 2020, as amended
CANCER GENETICS, INC
Biotechnology
NY
2021
Form of Wainwright Warrants dated February 16, 2021
CANCER GENETICS, INC
Biotechnology
NY
2021
Form of Placement Agent Warrants
CANCER GENETICS, INC
Biotechnology
2021
At The Market Offering Agreement by and between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC, dated December 2, 2020
CANCER GENETICS, INC
Biotechnology
NY
2020
Form of Underwriter Warrants of Cancer Genetics, Inc
CANCER GENETICS, INC
Biotechnology
NY
2020
Description of Securities
CANCER GENETICS, INC
Biotechnology
DE
2020
Standstill Agreement #2, between Iliad Research and Trading, L.P. and Cancer Genetics, Inc., dated May 3, 2019
CANCER GENETICS, INC
Biotechnology
2019
Offer Letter with William Finger, dated December 14, 2018
CANCER GENETICS, INC
Biotechnology
2019
Offer Letter with Michael McCartney, dated May 14, 2018
CANCER GENETICS, INC
Biotechnology
2019
Standstill Agreement, between Iliad Research and Trading, L.P. and Cancer Genetics, Inc., dated February 12, 2019
CANCER GENETICS, INC
Biotechnology
2019
Form of Placement Agent Warrants of Cancer Genetics, Inc
CANCER GENETICS, INC
Biotechnology
NY
2019
Form of Underwriter Warrants of Cancer Genetics, Inc
CANCER GENETICS, INC
Biotechnology
NY
2019
Offer Letter with Glenn Miles, dated November 16, 2018
CANCER GENETICS, INC
Biotechnology
2018
Engagement Letter between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC, dated as of December 3, 2017
CANCER GENETICS, INC
Biotechnology
NY
2017
RECITALS:
CANCER GENETICS, INC
Biotechnology
2014
Wells Fargo Bank, National Association
CANCER GENETICS, INC
Biotechnology
IA
2014
AMENDMENT NO. 3 TO AFFILIATION AGREEMENT
CANCER GENETICS, INC
Biotechnology
2013
AMENDMENT NO. 2 TO AFFILIATION AGREEMENT
CANCER GENETICS, INC
Biotechnology
2013
AMENDMENT NO. 1 TO AFFILIATION AGREEMENT
CANCER GENETICS, INC
Biotechnology
2012
900 Route 9 North Suite 301 Woodbridge, NJ 07095 phone: (732) 362-8800 fax ###-###-#### www.onyxequities.com
CANCER GENETICS, INC
Biotechnology
2012
INTER-CREDITOR AGREEMENT CANCER GENETICS, INC.
CANCER GENETICS, INC
Biotechnology
2012
AFFILIATION AGREEMENT
CANCER GENETICS, INC
Biotechnology
MN
2011
INTER-CREDITOR AGREEMENT CANCER GENETICS, INC.
CANCER GENETICS, INC
Biotechnology
2011
TSG Atlanta | Boston | New York, Laura White ***@***
CANCER GENETICS, INC
Biotechnology
2011
Cancer Genetics, Inc. 201 Route 17 North, 2nd Floor Rutherford, NJ 07675
CANCER GENETICS, INC
Biotechnology
NJ
2011
MEDICAL DIRECTOR AGREEMENT
CANCER GENETICS, INC
Biotechnology
NJ
2011
TSG 1230 Peachtree St. NE, 24th Floor, Atlanta, GA 30309, USA Panna Sharma, CEO & Managing Partner ***@*** CONFIDENTIAL MATERIAL -2-
CANCER GENETICS, INC
Biotechnology
2011
AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
CANCER GENETICS, INC
Biotechnology
DE
2011